K-Pharm’s quantum leap into the global market: How Korea emerged as a pharmaceutical powerhouse along with K-Pop’s global invasion
First taking the globe by the storm with K-Pop and culture, Korea has now emerged as a strong player in the global pharmaceutical landscape. The Korean pharmaceutical industry not only holds diverse and enriched R&D pipelines, but also possesses a strong portfolio of stringent regulatory authority (SRA) approvals – an interesting market for European companies.
At this event, Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) will introduce the Korean pharmaceutical landscape and its unique strengths. Along with KPBMA, promising Korean pharmaceutical companies including Yuhan Corporation and Hanmi Pharmaceutical will discuss their R&D pipelines and areas for potential collaboration with European partners.
Join Basel Area Business & Innovation for an exceptional opportunity of networking with Korean pharmaceutical partners. This event is empowered by Innosuisse.
